NCT02671227View on ClinicalTrials.gov

Intrathecal Mg in Gynecologic Laparoscopic Surgeries.

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

January 31, 2017

Conditions
Gynecologic Laparoscopic Surgery
Interventions
DRUG

intrathecal Mg sulfate.

intrathecal Mg sulfate 50 mg.

DRUG

intrathecal bupivacaine 15 mg.

intrathecal bupivacaine 15 mg.

Trial Locations (1)

71515

Asiut university hospital, Asiut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02671227 - Intrathecal Mg in Gynecologic Laparoscopic Surgeries. | Biotech Hunter | Biotech Hunter